Stryker Corporation — Ethics Grade C-

Stryker Corporation receives an overall ethics grade of C- (42/100) on CancelCo's corporate accountability database. Sector: Healthcare. Market cap: Large Cap.

Category scores

• labor: 68
• privacy: 85
• consumer: 30
• environment: 75
• humanRights: 80

Documented incidents (3)

• Rejuvenate and ABG II Hip Recall (high, 2012) — Stryker recalled modular hip implants due to fretting and corrosion that caused tissue damage and metal poisoning in patients. The company settled thousands of lawsuits related to the defective design.
• Foreign Corrupt Practices Act Violations (medium, 2018) — The SEC charged Stryker for failing to maintain internal accounting controls regarding payments to foreign officials in India, China, and Kuwait to secure business. This was the company's second FCPA violation in five years.
• Surgical Suction Pump Warning (high, 2021) — The FDA issued a Class I recall, the most serious type, for Stryker's Neptune Waste Management System because it had not been cleared for safety and caused a fatal injury to a patient.

Documented good deeds

• Renewable Energy Transition — Stryker committed to reducing their absolute scope 1 and 2 carbon emissions by 20% by 2030 and achieved 100% renewable electricity in several European facilities.

Ethical alternatives

• Edwards Lifesciences — Stronger focus on specific cardiovascular niches with fewer broad product recalls and higher governance scores.